Contents
Download PDF
pdf Download XML
105 Views
67 Downloads
Share this article
Research Article | Volume 5 Issue 1 (Jan-June, 2024) | Pages 1 - 11
Investigating Anxiety and Depression among Patients with Diabetes in Primary Health Care Centers in Iraq /Thi-Qar
1
MSc, Department of Health Programs and Systems, Al-Nasr Sector Primary Health Care, Dhi Qar Health Department, 64014 ;
Under a Creative Commons license
Open Access
Received
Jan. 13, 2024
Revised
Jan. 28, 2024
Accepted
March 24, 2024
Published
April 30, 2024
Abstract
Investigating, Anxiety, Depression, Patients, Diabetes, Primary health care centers.
Keywords
INTRODUCTION:

One of the most prevalent public health issues, diabetes affects 387 million people worldwide, with type 2 diabetes accounting for over 90% of cases (DM type 2) [1]. Diabetes, which is currently the fourth most common cause of death and illness globally, is on the rise. It is imperative to attain optimal glycemic control at an early stage in order to avert complications and death [2]. Despite the fact that only 53.6% of type 2 diabetics reach the desired goal of a glycated hemoglobin (HbA1c) of less than 7% [3]. Personalized targets are recommended by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) based on a number of factors, including co-morbidities, patient preferences, needs, values, duration of diabetes, risk of hypoglycemia, costs, and the assurance of a patient-centered approach [4]. Targets of less than 6.5% for newly diagnosed patients and less than 7.5% for people receiving two or more medications are advised by the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom [5]. One of the main causes of not reaching these goals is the co-occurrence of psychological problems.

 

Roughly 10–20% of elderly people experienced symptoms of depression [6]. The risk is higher—between 25 and 33 percent—for people with chronic diseases [7]. According to Yaseen and Dauod (2019) [8], these illnesses have a detrimental impact on quality of life and have significant economical ramifications [9]. According to several studies (Lustman et al., 2000; Gross et al., 2005) [10-11],  diabetes patients have a higher prevalence of depression, which contributes to their poor glycemic control and complications. According to other research, depression is linked to both cognitive decline and physical disability, both of which are more common in people with diabetes [12-13]. And additionally imply that depression frequently has a prolonged course [14-15]. Depression and anxiety symptoms may arise as a result of the neuroendocrine abnormalities linked to diabetes mellitus (DM), such as elevated cortisol levels and changed dopamine concentrations [16-17]. The purpose of this research is to identify diabetes patients' levels of anxiety and despair. To ascertain the association between diabetes patients' anxiety and depression and demographic information like age, gender, etc. 

 

The International Diabetes Federation estimates that one in eleven persons worldwide suffers from diabetes, and that one in fifteen adults worldwide has impaired glucose tolerance. These statistics support the organization's claim that diabetes is "one of the largest global health emergencies of the 21st century." It is projected that these numbers will rise sharply, especially among urban residents, leading to an increase in medical and financial problems [18]. It is anticipated that this increase will bring the total amount spent on diabetes treatment to 12%. In Iraq, the total number of people affected by diabetes was 561000 in 1995 and 678000 in 2000; by 2025, that figure is predicted to rise to 1,739,000 [19]. According to Bromet et al. (2011) [20], the lifetime prevalence of depression, a highly serious illness, ranges from 11% in low-income nations to 15% in high-income ones. According to Hewlett et al. (2014) [21], there is a 50% lifetime risk of mental health issues, along with a significant decline in productivity and employment. In high-income countries, diabetes is thought to be the eighth cause of disability-adjusted life years, while depression and anxiety rank fourth [22]. The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) published by the American Psychiatric Association defines depression as a mood disorder that reunites multiple symptoms that impair an individual's functionality. Emotions, thoughts, and actions are disrupted by depression [23]. Depression is classified as a first episode, a recurrent or chronic episode, mild, moderate, or severe, with or without psychotic symptoms, according to the DSM-5. Research has demonstrated that there is a higher chance of depression in individuals with pre-diabetes and diabetes who are not yet diagnosed. Diabetes is more common in patients with a history of the illness than in healthy individuals. and could be two times higher in type 2 diabetics than in the general population [24]. 

 

Anxiety and depression can exacerbate the prognosis of diabetes, increase medication non-adherence 9, and lower health-related quality of life. Additionally, there is a risk of According to Rubin et al. (2008) [25], the risk of type 2 diabetes mellitus increases to 60%. There seems to be a reciprocal, intricate interaction between depression and diabetes. biological mechanisms, the understanding of which improves harmful consequences. Recent assessments of the literature have indicated three possible routes for the relationships. Diabetes may increase the likelihood of depression in the future, and depression may have a common etiology with diabetes. This cross-sectional study sought to highlight the need of screening for depression in individuals with diabetes and to demonstrate the connections between depression and diabetes [26].

MATERIAL AND METHOD:

Study design: Interview Study design conducted at the period of 1st of August 2023 to 20st November 2023 to determine anxiety and depression among patients with diabetes  in from the primary health care centers in Al-Nasr sector, Dhi Qar city, Iraq

 

Sitting: The study carried out at 4 the primary health care centers in Al-Nasr sector, Dhi Qar city, Iraq 

 

Sample: The study sample consisted of 200 male and female who were patients coming to the early detection unit and who were suffering from diabetes in 4 primary healthcare centers in Nasr sector. They were selected using a probability method (simple random sample) from 4 primary health care centers in Nasr sector.

 

Instrument: The study instrument is a questionnaire composed of 2 parts:

 

Part one: Part one: demographic data; This part consists of 6 items : Age , Gender, Level of education, Marital status, Disease duration, Sugar check.

 

Part two: Anxiety And Depression Scale; This part consists of 2 domain items. Each domain contains seven questions .

 

Data Collection: Data is collected by the researcher, and the researcher explains the study and the purpose of the sample and obtains the consent of the sample to participate in the study and then uses the Interview Study method to collect data from the sample. Data will be collected by the researcher through a face-to-face interview with the help of the nursing staff. 

 

Ethical consideration: The researcher explains the study and the objectives to the sample and asks them to participate in the study. After taking the sample agreement, the investigator collects the data through the use of the interview method.

 

Validity of the Questionnaire 

Validity is concerned with the extent to which an instrument corresponds. The content validity of the instrument was established through a panel of (4) experts from different specialties. The results of the review of the questionnaire by the experts revealed that all of the experts agree that   items of the study instrument are clear and adequate for the measurement of the phenomenon.

 

Data Analysis:  The descriptive purposes of the study were determined through the frequency distribution. The association of two proportions was evaluated by Chi-square tests. The predictors of depression in diabetes patients were determined through the univariate  analyses. The significant level was considered as a P-value of less than 0.05. All calculations were performed by Statistical Package for Social Sciences (SPSS, version 22).

RESULTS:

Table 1: distribution of the sociodemographic characteristic of sample

Variables

Frequency

Percent

Age

20-29

5

2.5

30-39

15

7.5

40-49

80

40.0

50-59

91

45.5

60-69

9

4.5

Total

200

100.0

Mean and standard deviation 49.8±7.775

Gender

Female

104

52.0

Male

96

48.0

Total

200

100.0

Education

Secondary school 

71

35.5

Institute

62

31.0

BSN

54

27.0

Higher education

13

6.5

Total

200

100.0

Marital status

Single

1

.5

Married

181

90.5

Single

8

4.0

Widow

10

5.0

Total

200

100.0

Diseases diagnosis period

Mean and standard deviation 7.495±3.086

 

This finding  in table 1 shows that 45.5% of sample at age (50-59) years, 52% of them were females, 35.5% of them had secondary school graduated, 90.5% of them married and the mean of DM diagnosis period was 7.495.

 

Table 2: distribution of distribution of Anxiety and Depression among patients with DM

Variables

Frequency

Percent

Anxiety

Normal (0-7)

0

0

Borderline (8-10)

40

20.0

Severe (11 and more)

160

80.0

Total

200

100.0

Depression

Normal (0-7)

5

2.5

Borderline (8-10)

47

23.5

Severe (11 and more)

148

74.0

Total

200

100.0

 

This finding in table 2 and figure 1 shows that 80% and 74% of patients with DM had severe anxiety and depression respectively.

 

 

Figure 1 distribution of Anxiety and Depression among patients with DM

 

Table 3: relationship between Anxiety among patients with DM and sociodemographic characteristic

Variables

Anxiety

Total

Chi square

Borderline

Severe

Age

20-29

3

2

5

Chi=9.452

P=0.051

Sig.=NS

30-39

4

11

15

40-49

10

70

80

50-59

20

71

91

60-69

3

6

9

Total

40

160

200

Gender

Female

24

80

104

Chi=1.282

P=0.258

Sig.=NS

Male

16

80

96

Total

40

160

200

Education

Secondary school

11

60

71

Chi=3.218

P=0.359

Sig.=NS

Institute

11

51

62

BSN

15

39

54

Higher education

3

10

13

Total

40

160

200

Marital status

Single

0

1

1

Chi=5.425

P=0.143

Sig.=NS

Married

35

146

181

Single

4

4

8

widow

1

9

10

Total

40

160

200

 

P= p value, Sig= significant, HS= high significant, S=significant, NS= non- significant

In table 3, there is no significant statistical relationship between Anxiety among patients with DM and sociodemographic characteristic

 

Table 4: relationship between Depression among patients with DM and sociodemographic characteristic

Variables

Depression

Total

Chi square

Normal

Borderline

Severe

Age

20-29

0

0

5

5

Chi=8.755

P=0.363

Sig.=NS

30-39

0

6

9

15

40-49

1

18

61

80

50-59

4

19

68

91

60-69

0

4

5

9

Total

5

47

148

200

Sex

Female

1

21

82

104

Chi=3.748

P=0.154

Sig.=NS

Male

4

26

66

96

Total

5

47

148

200

Education

Secondary school

2

18

51

71

Chi=2.804

P=0.833

Sig.=NS

Institute

1

16

45

62

BSN

2

9

43

54

Higher education

0

4

9

13

Total

5

47

148

200

Marital status

Single

0

0

1

1

Chi=1.927

P=0.926

Sig.=NS

Married

5

41

135

181

Single

0

3

5

8

widow

0

3

7

10

Total

5

47

148

200

 

In table 4, there is no significant statistical relationship between Depression among patients with DM and sociodemographic characteristics.

DISCUSSION:

The purpose of the study being conducted by the author was to confirm the level of depression and anxiety in a sample of Iraqi patients with Type 2 diabetes who were receiving care in Al-Nasr medical centers. According to the study, 80% of the patients experience anxiety, and 74% experience depression. Population prevalence  of anxiety and depression based on the degree of diabetes mellitus and diabetes severity. Everywhere in the world is a different place. While an Iraqi study indicated that 37.2% of depression cases were reported in Babylon, Khamisa (2019) [27] found that a similar depression rate of 71.8% was identified in an adult Iranian sample [28].  a reduction in the depression score. As stated in affluent nations, for instance, in the US, between 2% to 28.8% [29], and in Greece, 33.4% [30].

 

According to the study, aging is a significant predictor of major anxiety and depression in people with type 2 diabetes. The outcome as it stands is debatable. That is all. While some researchers [28] have endorsed this, others [31] have not negative consequences for health. Older patients often report related quality of life [32]. As senior people endure a higher lack of support and use poorer  healthcare  services. Previous research has shown that being a woman is a strong predictor of depression severity. 26 Research indicates that women are twice as likely as men to have depression [33], and that estrogen levels may have an impact [34]. Women may also be more emotional and open because of the societal roles that are assigned to them, such as emotional expressiveness, submissiveness, and passivity.

 

Contrary to findings from earlier investigations, the current study indicated that the duration of DM was not substantially linked with depression. However, it should be noted that the length of the diabetes condition increases the complications associated with it [35], and as a result, depression risk increases [36].

 

Shows no significant association between anxiety and the following socio-demographic factors: age (0.051), gender (p = 0.258), Education (p = 0.359), marital status (p = 0.143).

 

shows no significant association between depression and the following socio-demographic factors: age (0.363), gender (p = 0.154), Education (p = 0.833), marital status (p = 0.926).

 

The depression and anxiety percentages among diabetes are divisive among studies globally. Some studies showed approximately similar results 56.1% [37] and 60.0% [38] for depression and 55.1% [39] and 57.9% [40] for anxiety respectively. Other studies in India, Malaysia, and Saudi Arabia reported a lower result 26.3% [41], 26.6% and 22.45% [42] for depression and 27.6% [43] and 28.5% [42], for anxiety respectively.

 

There are a number of plausible causes for the high rate of mental illnesses among diabetes in this study, including inadequate understanding and societal barriers that discourage general practitioners from treating these diseases' symptoms. The study was carried out during a period of unstable politics, a corrupt economy, and a lack of a health insurance system, which led to several societal complexities. Together, these elements led to comparatively elevated symptoms of anxiety and depression.

CONCLUSION:

The study revealed that a large percentage of diabetic patients suffered from anxiety and or depressive symptoms. The results should alert all physicians working in primary health centers to consider these symptoms since they have a direct impact in improving treatment.

 

Better strategies for the early identification and treatment of depression in patients with diabetes mellitus, as well as increased healthcare provider awareness, are imperative given that diabetes remains a major health concern in Iraq. Training programs on depression screening should be offered to medical professionals who care for patients with diabetes mellitus, and it would be beneficial to conduct additional research in Iraq to assess the possible link between type 2 DM and depression.

REFERENCE
  1. Ahmed Chetoui, Kamal Kaoutar, et al. "Epidemiology of diabetes in Morocco: review of data, analysis and perspectives." Int. J. Scientific Eng. Res 9 (2018): 1310-1316. https://www.researchgate.net/profile/Ahmed-Chetoui/publication/330579367_Epidemiology_of_diabetes_in_Morocco_review_of_data_analysis_and_perspectives/links/5c6ec731a6fdcc3028062875/Epidemiology-of-diabetes-in-Morocco-review-of-data-analysis-and-perspectives.pdf 
  2. Holman, Rury R., Harald Sourij, and Robert M. Califf. "Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes." The Lancet 383.9933 (2014): 2008-2017. https://doi.org/10.1016/S0140-6736(14)60794-7 
  3. Stone, Margaret A., et al. "Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study." Diabetes care 36.9 (2013): 2628-2638. https://doi.org/10.2337/dc12-1759 
  4. Inzucchi, Silvio E., et al. "Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes." Diabetes care 38.1 (2015): 140-149. https://doi.org/10.2337/dc14-2441 
  5. Chatterton, Hilary, et al. "Risk identification and interventions to prevent type 2 diabetes in adults at high risk: summary of NICE guidance." Bmj 345 (2012). https://doi.org/10.1136/bmj.e4624 
  6. Blazer, Dan G. "Depression in late life: review and commentary." The journals of gerontology series A: Biological sciences and medical sciences 58.3 (2003): M249-M265. https://doi.org/10.1093/gerona/58.3.M249 
  7. Ghosh, Anindita, and Amrita Deb. "Positive psychology interventions for chronic physical illnesses: A systematic review." Psychological Studies 62 (2017): 213-232. https://link.springer.com/article/10.1007/s12646-017-0421-y 
  8. Yaseen, Bnar Sardar, and Ali Shakir Dauod. "Symptoms of depression and anxiety among a Sample of Type 2 diabetic patients at Primary Health Care in Erbil city." Tikrit Journal of Pure Science 23.10 (2019): 5-13. https://www.iasj.net/iasj/download/c2e8cef74cfb71ec 
  9. Santos, Marcelo Justus dos, Henrique Coelho Kawamura, and Ana Lucia Kassouf. "Socioeconomic conditions and risk of mental depression: An empirical analysis for Brazilian citizens." Economics Research International 2012 (2012). https://downloads.hindawi.com/archive/2012/278906.pdf 
  10. Lustman, Patrick J., et al. "Depression and poor glycemic control: a meta-analytic review of the literature." Diabetes care 23.7 (2000): 934-942. https://doi.org/10.2337/diacare.23.7.934 
  11. Gross, Raz, et al. "Depression and glycemic control in Hispanic primary care patients with diabetes." Journal of general internal medicine 20.5 (2005): 460-466. https://doi.org/10.1111/j.1525-1497.2005.30003.x 
  12. Volpato, Stefano, et al. "Progression of lower-extremity disability in older women with diabetes: the Women’s Health and Aging Study." Diabetes care 26.1 (2003): 70-75. https://doi.org/10.2337/diacare.26.1.70 
  13. Vinkers, David J., et al. "Temporal relation between depression and cognitive impairment in old age: prospective population based study." Bmj 329.7471 (2004): 881. https://doi.org/10.1136/bmj.38216.604664.DE 
  14. Robert, D., Pat, J., Laura, J., & David, H. "Diabetes, Depression, and Quality of Life." Diabetes Care, vol. 27, no. 5, (2004), pp. 1066-1070. https://doi.org/10.2337/diacare.27.5.1066 
  15. de Groot, Mary, et al. "Depressive symptoms and type 2 diabetes mellitus in rural appalachia: an 18-month follow-up study." The International Journal of Psychiatry in Medicine 48.4 (2014): 263-277. https://doi.org/10.2190/PM.48.4.c 
  16. Björntorp, P., G. Holm, and R. Rosmond. "Hypothalamic arousal, insulin resistance and type 2 diabetes mellitus." Diabetic medicine 16.5 (1999): 373-383. https://doi.org/10.1046/j.1464-5491.1999.00067.x 
  17. Kleinridders, Andre, et al. "Insulin resistance in brain alters dopamine turnover and causes behavioral disorders." Proceedings of the National Academy of Sciences 112.11 (2015): 3463-3468. https://doi.org/10.1073/pnas.1500877112 
  18. Unwin, Nigel, Delice Gan, and David Whiting. "The IDF Diabetes Atlas: providing evidence, raising awareness and promoting action." Diabetes research and clinical practice 87.1 (2010): 2-3. https://doi.org/10.1016/j.diabres.2009.11.006 
  19. King, Hilary, Ronald E. Aubert, and William H. Herman. "Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections." Diabetes care 21.9 (1998): 1414-1431. https://doi.org/10.2337/diacare.21.9.1414 
  20. Bromet, Evelyn, et al. "Cross-national epidemiology of DSM-IV major depressive episode." BMC medicine 9.1 (2011): 1-16. https://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-9-90?report=reader 
  21. Hewlett, Emily, and Valerie Moran. Making mental health count: the social and economic costs of neglecting mental health care. OECD, 2014. https://catalog.lib.kyushu-u.ac.jp/ja/recordID/6286061/ 
  22. Whiteford, Harvey A., et al. "Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010." The lancet 382.9904 (2013): 1575-1586. https://doi.org/10.1016/S0140-6736(13)61611-6 
  23. undefined American Psychiatric Association. "Diagnostic and statistical manual of mental disorders." (2013): undefined. https://articles.researchsolutions.com/diagnostic-and-statistical-manual-of-mental-disorders/doi/10.1176/appi.books.9780890425596# 
  24. Roy, Tapash, and Cathy E. Lloyd. "Epidemiology of depression and diabetes: a systematic review." Journal of affective disorders 142 (2012): S8-S21. https://doi.org/10.1016/S0165-0327(12)70004-6 
  25. Rubin, Richard R., et al. "Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program." Diabetes care 31.3 (2008): 420-426. https://doi.org/10.2337/dc07-1827 
  26. Berge, Line Iden, and Trond Riise. "Comorbidity between type 2 diabetes and depression in the adult population: directions of the association and its possible pathophysiological mechanisms." International journal of endocrinology 2015 (2015). https://www.hindawi.com/journals/ije/2015/164760/abs/ 
  27. Khalighi, Zahra, et al. "The prevalence of depression and anxiety in Iranian patients with diabetes mellitus: A systematic review and meta-analysis." Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13.4 (2019): 2785-2794. https://doi.org/10.1016/j.dsx.2019.07.004 
  28. ALI, DONIA KREIT, KARWAN HAWEZ SULAIMAN, and RAGIB HASAN SANAAN. "PREVALENCE OF DEPRESSION AMONG A SAMPLE OF PATIENTS WITH TYPE II DIABETESMELLITUS." Duhok Medical Journal 12.2 (2018): 21-32. https://www.iasj.net/iasj/download/a3700e4d7fa2a09d 
  29. Li, Chaoyang, et al. "Prevalence of depression among US adults with diabetes: findings from the 2006 behavioral risk factor surveillance system." Diabetes care 31.1 (2008): 105-107. https://doi.org/10.2337/dc07-1154 
  30. Sotiropoulos, Alexios, et al. "Prevalence of depressive symptoms among non insulin treated Greek type 2 diabetic subjects." BMC research notes 1.1 (2008): 1-4. https://bmcresnotes.biomedcentral.com/articles/10.1186/1756-0500-1-101 
  31. Mikaliūkštienė, Aldona, et al. "Prevalence and determinants of anxiety and depression symptoms in patients with type 2 diabetes in Lithuania." Medical science monitor: international medical journal of experimental and clinical research 20 (2014): 182. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930682/ 
  32. Dudzińska, Marta, et al. "Social problems of diabetics. The influence of diabetes on patients’ daily, family and personal lives." Diabetologia Doświadczalna i Kliniczna 8.4 (2008): 150-149. https://www.researchgate.net/publication/287473559_Social_problems_of_diabetics_The_influence_of_diabetes_on_patients'_daily_family_and_personal_lives 
  33. Niraula, Kiran, et al. "Prevalence of depression and associated risk factors among persons with type-2 diabetes mellitus without a prior psychiatric history: a cross-sectional study in clinical settings in urban Nepal." BMC psychiatry 13.1 (2013): 1-12. https://bmcpsychiatry.biomedcentral.com/articles/10.1186/1471-244X-13-309 
  34. Archer, Johanna SM. "Relationship between estrogen, serotonin, and depression." Menopause 6.1 (1999): 71-78. https://journals.lww.com/menopausejournal/abstract/1999/06010/relationship_between_estrogen,_serotonin,_and.15.aspx 
  35. MIYAOKA, YOSHIKO, et al. "Impact of sociodemographic and diabetes‐related characteristics on depressive state among non‐insulin‐dependent diabetic patients." Psychiatry and clinical neurosciences 51.4 (1997): 203-206. https://doi.org/10.1111/j.1440-1819.1997.tb02583.x .
  36. Palinkas, L. A., E. Barrett‐Connor, and D. L. Wingard. "Type 2 diabetes and depressive symptoms in older adults: a population‐based study." Diabetic medicine 8.6 (1991): 532-539. https://doi.org/10.1111/j.1464-5491.1991.tb01646.x 
  37. Sun, Nianquan, et al. "Prevalence and determinants of depressive and anxiety symptoms in adults with type 2 diabetes in China: a cross-sectional study." BMJ open 6.8 (2016): e012540. https://doi.org/10.1136/bmjopen-2016-012540 
  38. Hall, Kirsty K., et al. "Association between depression, glycaemic control and the prevalence of diabetic retinopathy in a diabetic population in Cameroon." South African Journal of Psychiatry 23.1 (2017): 1-7. https://hdl.handle.net/10520/EJC-8d69cf0ff 
  39. Tovilla-Zarate, Carlos, et al. "Prevalence of anxiety and depression among outpatients with type 2 diabetes in the Mexican population." PloS one 7.5 (2012): e36887. https://doi.org/10.1371/journal.pone.0036887 
  40. Khuwaja, Ali Khan, et al. "Anxiety and depression among outpatients with type 2 diabetes: A multi-centre study of prevalence and associated factors." Diabetology & metabolic syndrome 2.1 (2010): 1-7. https://dmsjournal.biomedcentral.com/articles/10.1186/1758-5996-2-72 
  41. Rajput, Rajesh, et al. "Prevalence and predictors of depression and anxiety in patients of diabetes mellitus in a tertiary care center." Indian journal of endocrinology and metabolism 20.6 (2016): 746. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105554/ 
  42. Alduraywish, Abdulrahman, et al. "Depression and anxiety and their correlates in patients with diabetes mellitus in Al-Jouf Region, Saudi Arabia." Clin Med Diagn 7.2 (2017): 48-56. https://www.academia.edu/download/99216319/showpaperpdf.pdf 
  43. Tan, K. C., et al. "Depression, anxiety and stress among patients with diabetes in primary care: a cross-sectional study." Malaysian family physician: the official journal of the Academy of Family Physicians of Malaysia 10.2 (2015): 9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826577/ 
  44.  
Recommended Articles
Research Article
A Study to Determine The Role of Nursing In Comprehending The Reasons Why So Many Young Women Give Birth to Unwanted, Unplanned Children
...
Published: 29/07/2024
Download PDF
Research Article
Factors affecting pre hospital treatment delay in acute myocardial infarction patients
...
Published: 30/05/2022
Download PDF
Research Article
Urinary Tract Infection in listless babies
Published: 11/10/2024
Download PDF
Research Article
Capacity of Communities in Addressing Social Determinants of Health towards Care and Support of Vulnerable Children: Case of Suba –Sub County Nyanza Kenya
...
Published: 30/05/2021
Download PDF
Chat on WhatsApp
Flowbite Logo
PO Box 101, Nakuru
Kenya.
Email: office@iarconsortium.org

Editorial Office:
J.L Bhavan, Near Radison Blu Hotel,
Jalukbari, Guwahati-India
Useful Links
Order Hard Copy
Privacy policy
Terms and Conditions
Refund Policy
Shipping Policy
Others
About Us
Contact Us
Online Payments
Join as Editor
Join as Reviewer
Subscribe to our Newsletter
+91 60029-93949
Follow us
MOST SEARCHED KEYWORDS
Copyright © iARCON Internaltional LLP . All Rights Reserved.